Literature DB >> 17096055

Predicting patients at low probability of requiring postmastectomy radiation therapy.

Anees B Chagpar1, Charles R Scoggins, Robert C G Martin, Earl F Cook, Terry McCurry, Nana Mizuguchi, Kristie J Paris, David J Carlson, Alison L Laidley, Souzan E El-Eid, Terre Q McGlothin, Kelly M McMasters.   

Abstract

BACKGROUND: Postmastectomy radiation therapy (PMRT) is recommended for patients with four or more positive lymph nodes (LN+). Given the ramifications of PMRT for immediate reconstruction, we sought to create a model using preoperative and intraoperative factors to predict which patients with a positive sentinel lymph node will have less than four LN+.
METHODS: The database from a prospective multicenter study of 4,131 patients was used for this analysis. Patients with one to three positive sentinel lymph nodes (SLN) and tumors < 5 cm (n = 1,133) in size were randomly divided into a training set (n = 580) and a test set (n = 553). Multivariate logistic regression was used on the training set to create a prediction rule that was subsequently validated in the test set.
RESULTS: Median patient age was 57 (range, 27-100) years, and median tumor size was 2.0 (range, 0.2-4.8) cm. In the training set, factors associated with having four or more LN+ on multivariate analysis were: tumor size [odds ratio (OR) = 2.087; 95% confidence interval (CI): 1.307-3.333, P = 0.002), number of positive SLN (P < 0.0005), and proportion of positive SLN (OR = 3.602; 95% CI: 2.100-6.179, P < 0.005). A predictive model was established with a point assigned to each positive SLN, T2 (vs. T1), and if proportion of positive SLN was > 50%, for a maximum of five points. In both the training and test sets, patients with one point had a low probability of having four or more LN+ (3.8% and 3.3%, respectively).
CONCLUSION: Tumor size, number of positive SLN, and the proportion of positive SLN influence whether patients will have four or more LN+. A simple model can predict the probability of requiring PMRT.

Entities:  

Mesh:

Year:  2006        PMID: 17096055     DOI: 10.1245/s10434-006-9107-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

1.  Accuracy of a multidisciplinary team-led discussion in predicting postmastectomy radiotherapy.

Authors:  M Wilson; M Dordea; A Light; M P Serra; S R Aspinall
Journal:  Ann R Coll Surg Engl       Date:  2015-04       Impact factor: 1.891

2.  Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status.

Authors:  Gary M Freedman; Barbara L Fowble; Tianyu Li; E Shelley Hwang; Naomi Schechter; Karthik Devarajan; Penny R Anderson; Elin R Sigurdson; Lori J Goldstein; Richard J Bleicher
Journal:  Breast J       Date:  2014-05-26       Impact factor: 2.431

3.  Predicting four or more metastatic axillary lymph nodes in patients with sentinel node-positive breast cancer: assessment of existent risk scores.

Authors:  Benjamin Zendejas; Tanya L Hoskin; Amy C Degnim; Carol A Reynolds; David R Farley; Judy C Boughey
Journal:  Ann Surg Oncol       Date:  2010-04-29       Impact factor: 5.344

4.  Axillary lymph node clearance in patients with positive sentinel lymph node biopsy.

Authors:  T Hussain; P J Kneeshaw
Journal:  Ann R Coll Surg Engl       Date:  2014-04       Impact factor: 1.891

5.  One-step nucleic acid amplification assay for intraoperative prediction of advanced axillary lymph node metastases in breast cancer patients with sentinel lymph node metastasis.

Authors:  Michiyo Kubota; Yoshifumi Komoike; Mika Hamada; Wataru Shinzaki; Tatsuya Azumi; Yukihiko Hashimoto; Shigeru Imoto; Yoshifumi Takeyama; Kiyotaka Okuno
Journal:  Mol Clin Oncol       Date:  2015-12-07

6.  Tangential vs. defined radiotherapy in early breast cancer treatment without axillary lymph node dissection: a comparative study.

Authors:  Mirko Nitsche; Nils Temme; Manuela Förster; Michael Reible; Robert Michael Hermann
Journal:  Strahlenther Onkol       Date:  2014-05-17       Impact factor: 3.621

7.  Prognostic value of the lymph node ratio for lymph-node-positive breast cancer- is it just a denominator problem?

Authors:  Upali W Jayasinghe; Nirmala Pathmanathan; Elisabeth Elder; John Boyages
Journal:  Springerplus       Date:  2015-03-11

8.  Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay.

Authors:  Victoria Fung; Stan Kohlhardt; Patricia Vergani; Gregory J Zardin; Norman R Williams
Journal:  Mol Clin Oncol       Date:  2017-09-01

9.  Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.

Authors:  Kenzo Shimazu; Nobuaki Sato; Akiko Ogiya; Yoshiaki Sota; Daisuke Yotsumoto; Takashi Ishikawa; Seigo Nakamura; Takayuki Kinoshita; Hitoshi Tsuda; Yasuyo Ohi; Futoshi Akiyama; Shinzaburo Noguchi
Journal:  Ann Surg Oncol       Date:  2018-07-05       Impact factor: 5.344

10.  Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool.

Authors:  Ingrid van den Hoven; David van Klaveren; Nicole C Verheuvel; Raquel F D van la Parra; Adri C Voogd; Wilfred K de Roos; Koop Bosscha; Esther M Heuts; Vivianne C G Tjan-Heijnen; Rudi M H Roumen; Ewout W Steyerberg
Journal:  J Surg Oncol       Date:  2019-07-23       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.